Karen Gylys

Affiliations: 
Neuroscience University of California, Los Angeles, Los Angeles, CA 
Area:
Neurobiology Biology
Google:
"Karen Gylys"
Mean distance: 53433
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Bilousova T, Melnik M, Miyoshi E, et al. (2019) Apolipoprotein E/Aβ Complex Accumulates in AD Cortical Synapses via apoE Receptors and Is Enhanced by APOE4. The American Journal of Pathology
Bilousova T, Elias C, Miyoshi E, et al. (2018) Suppression of tau propagation using an inhibitor that targets the DK-switch of nSMase2. Biochemical and Biophysical Research Communications
Ma QL, Teng E, Zuo X, et al. (2018) Neuronal pentraxin 1: A synaptic-derived plasma biomarker in Alzheimer's disease. Neurobiology of Disease
Abud EM, Ramirez RN, Martinez ES, et al. (2017) iPSC-Derived Human Microglia-like Cells to Study Neurological Diseases. Neuron. 94: 278-293.e9
Gonzalez B, Abud EM, Abud AM, et al. (2017) Tau Spread, Apolipoprotein E, Inflammation, and More: Rapidly Evolving Basic Science in Alzheimer Disease. Neurologic Clinics. 35: 175-190
Gylys KH, Bilousova T. (2017) Flow Cytometry Analysis and Quantitative Characterization of Tau in Synaptosomes from Alzheimer's Disease Brains. Methods in Molecular Biology (Clifton, N.J.). 1523: 273-284
Prieto GA, Trieu BH, Dang CT, et al. (2016) Pharmacological rescue of long-term potentiation in Alzheimer diseased synapses. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience
Zhang L, Trushin S, Christensen TA, et al. (2016) Altered brain energetics induces mitochondrial fission arrest in Alzheimer's Disease. Scientific Reports. 6: 18725
Bilousova T, Miller CA, Poon WW, et al. (2016) Synaptic Amyloid-β Oligomers Precede p-Tau and Differentiate High Pathology Control Cases. The American Journal of Pathology. 186: 185-98
Hwang KS, Lazaris AS, Eastman JA, et al. (2015) Plasma BDNF levels associate with Pittsburgh compound B binding in the brain. Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring. 1: 187-193
See more...